Erivedge 150 (Vismodegib Capsule) 150mg

ERIVEDGE 150 (Vismodegib 150mg) capsules are prescribed for adults with advanced skin cancer types like basal cell carcinoma. This targeted therapy helps manage certain conditions when other treatments aren’t suitable. Store at room temperature and follow healthcare provider guidance closely.

Strength

150mg

Pack Size

28s

Storage

Ambient

Manufacturer / TM Owner

Roche

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

ERIVEDGE 150 is used to treat adults with metastatic basal cell carcinoma or locally advanced basal cell carcinoma that has recurred after surgery or radiation. It targets the hedgehog pathway to slow cancer cell growth in specific skin cancer cases. Patients often ask, 'what is ERIVEDGE 150 used for' when exploring treatment options for advanced basal cell carcinoma.

Side Effects

Common effects of ERIVEDGE 150 may include muscle spasms, hair loss, and changes in taste. Some users report fatigue or nausea, while others experience weight loss or joint pain. These effects vary by individual and should be monitored with medical supervision.

Precautions & Warnings

ERIVEDGE 150 should be handled with care; avoid crushing or opening capsules due to potential harm. Pregnant individuals or those planning pregnancy should not take this medication, as it may cause severe birth defects. Regular blood tests and check-ups are recommended during treatment.

Avoid Interactions

ERIVEDGE 150 may interact with strong CYP3A inhibitors or inducers, altering its effectiveness. Grapefruit products can increase side effects, while certain supplements like St. John’s Wort may reduce efficacy. Always inform your healthcare provider about all medications and supplements in use.

Frequently Asked Questions

ERIVEDGE 150 is used to treat adults with advanced basal cell carcinoma, including metastatic or locally advanced cases not treatable by surgery or radiation.

Store ERIVEDGE 150 capsules at room temperature, away from moisture and heat, and keep out of reach of children.

No, ERIVEDGE 150 can cause severe birth defects and should not be taken during pregnancy or by those planning pregnancy.

Common side effects include muscle spasms, hair loss, fatigue, nausea, and changes in taste or weight.

Yes, it may interact with CYP3A inhibitors, inducers, or grapefruit products, affecting its safety or effectiveness.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.